The first experience with brolucizumab for neovascular age-related macular degeneration
<p> <b>A.N. Kulikov, D.S. Maltsev, A.Yu. Malafeeva, S.M. Perminova, V.R. Zhalimova, <br> A.S. Vasiliev, A.A. Kazak</b> </p> <p> <b>S.M. Kirov Military Medical Academy, St. Petersburg, Russian Federation</b> </p> <p> <i><b>A...
Saved in:
Main Authors: | A.N. Kulikov, D.S. Maltsev, A.Yu. Malafeeva, S.M. Perminova, V.R. Zhalimova, A.S. Vasiliev, A.A. Kazak |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Prime-Media
2022-05-01
|
Series: | РМЖ "Клиническая офтальмология" |
Online Access: | http://clinopht.com/upload/iblock/796/7962935cfc5d0f0f1c1388eae1b8c5fe.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of neovascular age-related macular degeneration: one year real-life results with intravitreal Brolucizumab
by: Settimio Rossi, et al.
Published: (2025-01-01) -
The initial results of using brolucizumab (Beovu®), an angiogenesis inhibitor, for choroidal neovascularization in patients with age-related macular degeneration
by: N.S. Zhayvoronok, et al.
Published: (2022-11-01) -
Treatment for neovascular age-related macular degeneration: reasonable expectations of physicians and patients
by: A.B. Durasov
Published: (2021-09-01) -
Intravitreal Brolucizumab for Choroidal Neovascularization Associated to Angioid Streaks
by: Somnath Chakraborty, et al.
Published: (2022-01-01) -
Early OCT Angiography Changes of Macular Neovascularization in Patients with Exudative AMD Treated with Brolucizumab in a Real-World Setting
by: Anne Rübsam, et al.
Published: (2022-01-01)